Financial Management Professionals’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Financial Management Professionals's RXRX Position: Q3 2026 in Review
Financial Management Professionals held its Recursion Pharmaceuticals (RXRX) position steady in Q3 2026 at 1,410 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #653.
Financial Management Professionals first reported a position in RXRX in Q1 2024 and has held it in 10 quarters since. The position peaked at $8K in Q1 2024. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Financial Management Professionals held 1,410 shares of Recursion Pharmaceuticals worth $5.82K as of Q3 2026.
- Financial Management Professionals left its Recursion Pharmaceuticals share count unchanged in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q3 2026, its #653 holding.
- Financial Management Professionals first reported a position in Recursion Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- Financial Management Professionals's Recursion Pharmaceuticals position peaked at $8K in Q1 2024.
- 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Financial Management Professionals's 13F filing for Q3 2026, filed 23 Oct 2026.